Concepedia

Author

Alba Rubio‐San‐Simón

Hospital Infantil Universitario Niño JesúsORCID

Also Known As

A SIMON, A Simon, A. Rubio, A. Rubio San Simón, A. Rubio-San-Simón, A. Simon, Alba Rubio, Alba Rubio San Simón, Alba Rubio-San-Simon, Alba Rubio-San-Simón

79

Publications

300

Citations

10

H-Index

13

Concepts

All Affiliations

Hospital Infantil Universitario Niño JesúsHospital Universitari i Politècnic La FeHospital Sant Joan de Déu BarcelonaVall d'Hebron Hospital UniversitariBambino Gesù Children's Hospital
AR

About

Alba Rubio‐San‐Simón is an author at Hospital Infantil Universitario Niño Jesús specializing in medicine, clinical trials, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

66

2

Clinical Trials

3

3

66

3

Health Sciences

1

1

29

4

Global Health

1

1

22

5

Cancer Therapeutics

1

1

29

Alba Rubio‐San‐Simón

×

7

Publications

155

Citations

7

H-Index

YearCitations

Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study

Teena Bhatla, Laura Hogan, David T. Teachey,

Blood

2024

40

BEACON-Immuno: Results of the dinutuximab beta (dB) randomization of the BEACON-Neuroblastoma phase 2 trial—A European Innovative Therapies for Children with Cancer (ITCC–International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN) trial.

Juliet C. Gray, Lucas Moreno, Rebekah Weston,

Journal of Clinical Oncology

2022

29

Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium

Alba Rubio‐San‐Simón, Nicolás André, Maria Giuseppina Cefalo,

European Journal of Cancer

2020

22

Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22<sup>+</sup> acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial

Edoardo Pennesi, Erica Brivio, Anneke C. J. Ammerlaan,

Haematologica

2024

17

The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial

Jaume Mora, Daniel A. Morgenstern, Loredana Amoroso,

Nature Communications

2025

17

Congenital transmission of Chagas disease in a non-endemic area, is an early diagnosis possible?

Laura Francisco-González, Alba Rubio‐San‐Simón, María Isabel González-Tomé,

PLoS ONE

2019

15

Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

Alba Rubio‐San‐Simón, Jaime Verdú‐Amorós, Raquel Hladun,

Clinical & Translational Oncology

2020

15

Page 1